Symbols

Symbols

ARGX

ARGX

Argenx Receives Health Canada Approval for VYVGART SC as Monotherapy for CIDP Treatment

Argenx's 15-Min Chart Shows RSI Oversold, KDJ Golden Cross Signal.

Tuesday Nov 04, 2025

Argenx's 15min chart signals Bollinger Bands Narrowing, KDJ Death Cross, Bearish Marubozu.

Argenx: Piper Sandler Reiterates Overweight, PT Raised to $930 from $820

Argenx's 15-minute chart triggers RSI overbought, KDJ death cross signal.

Friday Oct 31, 2025

argenx Earnings Growth Outpaces Belgian Market and Local Revenue Benchmarks

Argenx's 15min chart triggered Bollinger Bands expansion, bearish Marubozu formation

Argenx' 15-Min Chart Shows MACD and KDJ Death Crosses Triggered

Argenx: TD Cowen raises Buy rating, PT increases to $1146 from $800.

RBC Capital Upgrades Argan, PT Raised to $860 from $850.

Evercore ISI raises Argenx PT to $910 from $775, maintains Outperform.

Argenx: HC Wainwright Raises Buy Rating to $915, PT Raised to $915 from $774.

Thursday Oct 30, 2025

Argenx and Insmed Report Q3 Earnings, Shares Rise Amid Bullish Reports

argenx Q3 rev. $1.13 bln, 5 registrational study readouts expected in 2026

argenx Q3 2025: $1.13B in Global Product Net Sales, VYVGART Expansion Plans, and Five Registrational Study Readouts in 2026

Wednesday Oct 29, 2025

Argenx's 15min chart signals Bollinger Bands Narrowing, KDJ Death Cross, Bearish Marubozu.

ArgenX's 15-Minute Chart Triggers MACD Death Cross, Bearish Marubozu Pattern

VYVGART shows clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes.

New Data Highlights VYVGART's Efficacy and Safety in Myasthenia Gravis Patients Across All Subtypes.

Tuesday Oct 28, 2025

ArgenX's 15-Min Chart: KDJ Golden Cross, Bullish Marubozu Signal